Work

Avaliação pré-clínica do potencial terapêutico de uma biomassa de folhas de Vaccinium corymbosum L (mirtilo) num modelo experimental de Esclerose Múltipla

Year: 2021
Type: dissertation
Abstract: Multiple Sclerosis (MS) is a demyelinating autoimmune disease displaying neurological disability, for which there are still no available therapies targeting the core of the disease: demyelination and remyelination. Nutritional patterns compose one of the risk factors for MS development. These are modifiable lifestyle components that can inspire the creation of nutraceutical strategies of complementary nature.Several plants’ leaves have been revealing to be important sources of bioactive compounds, blueberry bushes’ leaves composing a great example, standing out because of its expressive beneficial properties which arise from an elevated phenolic compounds’ and dietary fiber contents. Nevertheless, typical processing techniques restrict the organism’s access to a large portion of these components. Hence, our group developed an innovative biotechnological methodology for sustainable leaves’ processing, resulting in a blueberries’ leaves biomass (BB) with increased health-promoting potential.After a thorough evaluation of the BB’s safety profile in mice, a dose of 500 mg/kg was selected. To assess BB’s nutraceutical potential in experimental MS, the cuprizone intoxication model was employed. The obtained results suggest a marked central/systemic antioxidant activity upon BB biomass intake, which reflected as modulated expression/activity of SOD, one key enzyme composing the biological antioxidant system. Moreover, BB biomass was able to counteract intestinal Treg/Th17 imbalance paralleling the peak of demyelination, clearly highlighting BB’ immunomodulatory profile. Remyelinating properties were likewise evidenced by the increased expression of myelin-associated genes in whole brain (MBP, PLP) as well as a more intense myelin staining (KB histology) in cerebellum samples. Collectively, data presented herein points to BB biomass efficacy to modulate active gut-to brain communications in experimental MS, particularly in the remyelination phase of the disease. The BB biomass features highlighted in this work open new avenues for its use as non-pharmacological therapy in MS, potentially through its integration as a high-added value ingredient in functional foods and/or nutraceuticals with prebiotic activity.
Author: Ferreira, Ana Carolina Marques
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W6995866740
Cites: 120
Cited by:
Related to: 10